NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer
Interventions: DRUG: Everolimus
Sponsor: Jenny C. Chang, MD
Collaborators: The Methodist Hospital Research Institute